Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Henry

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|October 1, 1994
Clinical application of recombinant erythropoietin in anemic cancer patientsD H Henry
Seminars in Hematology|October 1, 1993
Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancerD H Henry
Cancer Practice|July 1, 1996
Recombinant human erythropoietin treatment of anemic cancer patientsD H Henry
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1994
The management of cancer anemiaD H Henry
Seminars in Oncology|June 1, 1992
Changing patterns of care in the management of anemiaD H Henry
Seminars in Oncology|July 22, 1998
Epoetin alfa and high-dose chemotherapyD H Henry
Seminars in Oncology|July 22, 1998
Experience with epoetin alfa and acquired immunodeficiency syndrome anemiaD H Henry
Seminars in Oncology|April 1, 1994
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studiesD H Henry, R I Abels
Current Opinion in Hematology|March 1, 1995
Clinical use of erythropoietinD H Henry, J L Spivak
American Journal of Hematology|January 1, 1984
Heparin-induced thrombocytopenia: a prospective studyR A Johnson, K H Lazarus, D H Henry
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|October 1, 1994
Clinical application of recombinant erythropoietin in anemic cancer patientsD H Henry
Seminars in Hematology|October 1, 1993
Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancerD H Henry
Cancer Practice|July 1, 1996
Recombinant human erythropoietin treatment of anemic cancer patientsD H Henry
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1994
The management of cancer anemiaD H Henry
Seminars in Oncology|June 1, 1992
Changing patterns of care in the management of anemiaD H Henry
Seminars in Oncology|July 22, 1998
Epoetin alfa and high-dose chemotherapyD H Henry
Seminars in Oncology|July 22, 1998
Experience with epoetin alfa and acquired immunodeficiency syndrome anemiaD H Henry
Seminars in Oncology|April 1, 1994
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studiesD H Henry, R I Abels
Current Opinion in Hematology|March 1, 1995
Clinical use of erythropoietinD H Henry, J L Spivak
American Journal of Hematology|January 1, 1984
Heparin-induced thrombocytopenia: a prospective studyR A Johnson, K H Lazarus, D H Henry
Pageof 4